/
As a matter of public policy, these regulatory bodies are responsible for safeguarding the integrity of the securities and other financial markets and protecting the interests of investors in those markets. These regulatory bodies have broad powers to promulgate and interpret, investigate and sanction non-compliance with their laws, rules and regulations.
$113.80
$1.70 (-1.47%)
EOD Jul 17, 2026
29.14% net margin is above average for a financial institution, suggesting strong underwriting or fee income alongside controlled credit costs.
Revenue growth slowed to 3.6%, essentially flat. This is a business that needs a catalyst.
Net income declined 10% YoY, profitability momentum has weakened.
13.5x earnings. In line with financial-sector norms. The question is whether the current credit environment supports sustained earnings at this level.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$871M
▲ +3.6% YoY
Net Income (TTM)
$309M
▼ -10.0% YoY
Net Margin
35.52%
P/E
13.5x
Balance Sheet
Total Assets
$2.30B
Equity
$1.19B
Total Debt
$292M
Cash & Equiv.
$377M
5Y CAGR: +4.2%
Continue Research
At a P/E of 13.5 and a price-to-free-cash-flow of 14.9, MarketAxess Holdings (MKTX) trades around a two-stage DCF intrinsic value of about $134.95 per share, so at $113.80 the stock looks around fair value (18.6% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, MarketAxess Holdings scores 77/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 2.8%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $134.95 per share for MKTX, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $101.22. At today's $113.80, that puts the stock about 18.6% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
MarketAxess Holdings scores 77 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 40.7% operating margin and a 19.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, MarketAxess Holdings pays a regular dividend of about $3.23 per share per year (typically in quarterly installments), a yield of roughly 2.8% at the current price. That is a payout ratio of about 36.9% of earnings, so the dividend is amply covered by earnings. MarketAxess Holdings has grown the dividend at roughly 3.7% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For MKTX's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. MKTX currently trades around its estimated intrinsic value and scores 77/100 on quality (solid). It also yields about 2.8%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.